Abstract: Objective: to study the association of FTO gene rs9939609 variant in Sri Lankan women with PCOS.
Introduction
Polycystic ovary syndrome (PCOS) is the commonest endocrine disorder in women of reproductive age (Balen et al., 1995) . Diagnosis of PCOS is based on the "Rotterdam criteria", which require the presence of two of the three following features: polycystic ovaries, anovulation and androgen excess (clinical and or biochemical). Genome-wide association study identified the fat mass and obesity-associated (FTO) gene as an obesity susceptibility gene (Frayling et al., 2007) . The human FTO gene is located on chromosome 16 and expressed in a wide range of tissues, including the adipose tissue and specific areas of the brain and muscles, suggesting its potential role in body weight regulation (Wehr et al., 2010) . Several single nucleotide polymorphisms (SNP) of the FTO gene have been described. The variant FTO rs9939609 is the most extensively studied, located within the first FTO intron which has two alleles, A and T, the former has been linked to an increased risk for both obesity and type 2 diabetes mellitus (De Luis et al., 2013) .
Given the high prevalence of obesity in women with PCOS, we hypothesized obesity susceptibility gene may play an important role in the development of PCOS. In this study, we aimed to identify the association of FTO gene variant rs9939609 with PCOS susceptibility in Sri Lankan women with PCOS.
Materials and Methods
The study was approved by the Ethical Review Committee, Faculty of Medicine, University of Colombo, where the study was conducted. Written informed consent was obtained from all participants. Subjects were recruited from the Endocrine Clinic of the University Obstetrics and Gynaecology Department, De Soysa Maternity Hospital, Colombo, Sri Lanka. Diagnosis of PCOS was based on the Rotterdam criteria. This is a case control study, consisting of 55 cases and 110 controls.
Recruitment of Subjects: Women whose symptoms manifested from adolescent years (11) (12) (13) (14) (15) (16) (17) (18) (19) years WHO), with all 3 diagnostic criteria present when aged between 16-19 years (Anovular PCOS, hyperandrogenism and polycystic ovaries on ultrasound) were recruited as cases. Women who are asymptomatic, non-androgenic, normal cycling, in whom PCOS was objectively excluded by clinical, biochemical and ultrasound assessment, were recruited as controls.
Biochemical evaluation: Serum kisspetin and testosterone levels were determined by enzyme linked immunoassay kit method (ELISA) (Phoenix Pharmaceuticals Inc., Belmond, CA and Teco Diagnostics, USA respectively) as per manufactures" recommendation.
DNA extraction and Genotyping: 2ml of venous blood was collected into EDTA tubes from each subject and DNA was extracted using kit method (Promega, USA) according to the manufacture"s protocol. The FTO SNP rs9939609 was genotyped using tetra ARMS PCR. Primers were designed using the software primer1.soton.ac.uk/primer1.html. Following primers were used: Fout: 5'-TGG CTC TTG AAT GAA ATA GGA TTC AGA A-3'; Rout: 5'-AGC CTC TCT ACC ATC TTA TGT CCA AAC A-3' ; Fin: 5'-TAG GTT CCT TGC GAC TGC TGT GAA TAT A-3' ; Rin: 5'-GAG TAA CAG AGA CTATCC AAG TGC ATC TCA-3'. The T allele is detected by a 178bp amplicon and A allele is detected by a 201bp amplicon. The product size of the outer primers is 321 bp (figure 1). Following PCR cycle conditions were used to amplify the target region; initial denaturation at 94°C for 5 min, followed by 40 cycles of denaturation at 94°C for 30 s, annealing at 53°C for 25 s, extension at 72°C for 25 s and final extension at 72°C for 10 minutes. PCR products were run on ethidium bromide-stained 2% agarose gels.
Tetra ARMS PCR results were validated with high resolution melting (HRM) analysis. PCR primers for HRM analysis was designed based on the principle of competitive amplification of differentially melting amplicons (CADMA) (Borgbo et al., 2014) . Following primers were used for HRM analysis; A-Allele (5" > 3") TAT GTT CAT TGC GAC TGC TGT GAA TAT A; T-allele (5" > 3") TAG GCT CCT CGC GAC TGC TGT GAA TAT T; Common Reverse (5" > 3"): GAG TAA CAG AGA CTA TCC AAG TGC ATC AC. The PCR cycling conditions for HRM analysis was; initial denaturation at 95 °C for 15 min, followed by 40 cycles of 95 °C for 15 s, 60 °C for 20 s, 72 °C for 20 s. HRM was performed from 65 to 95 °C with a temperature increase of 0.1 °C/s with 50 acquisitions/°C. For high resolution melt curve analysis, Precision melt analysis software version 1.2 was applied.
Statistical Analysis
The Kolmogorov-Smirnov test was used to test the normality of distribution. Values with a biological distribution are presented as mean ± standard error for mean. Comparison of means between those with PCOS and controls was performed with the independent sample t test for normal values. Chi-square test was used for comparison of frequency for genotype analysis and it is also used for describing the correlation between genetic alleles with other numeric variables. All analyses were performed by SPSS software (v.18.0 SPSS, Inc., Chicago, IL). The level of significance was set as 5%.
Results
Demographic, clinical and hormonal characteristics of women with PCOS and controls were summarized in Table 1 . No significant difference in age, fasting blood glucose level and waist to hip ratio was observed. Women with PCOS had significantly higher BMI and mFG score. In addition, serum kisspeptin and testosterone concentrations were significantly higher in women with PCOS (kisspeptin -4.873 nmol/L; testosterone - Significant difference in FTO gene mutation was found with frequent association in PCOS patients when compared with control group. High frequency of A allele was observed in PCOS group. The frequency of T allele (normal allele) was significantly higher in controls (PCOS -AA= 40%, AT=23.6%, TT=36.3%; Controls AA = 13.6%, AT=20.9%, TT=65.4%; p<0.05). The A allele carrier genotype (AA and AT) frequencies were also significantly greater in PCOS than controls (63.6% vs 34.5%; AT and AA vs TT genotype, OR =3.32, p=0.001, 95% CI=1.69 -6.52). Furthermore, significant correlation was found between FTO gene and BMI (chi square value = 17.05, p<0.05). 
Discussion
The community prevalence of PCOS ranges between 2% to 11% in various countries with ethnic diversity in its age specific prevalence (Wijeyaratne et al., 2013) and the community prevalence of PCOS in young premarital Sri Lankan women is 6.3 % ( Kumarapeli et al., 2008) . It is reported that 40-80% of PCOS women are overweight or obese (Barber et al., 2006 , Wher et al., 2010 . Since the prevalence of obesity in PCOS is high, we can assume that genes associated with obesity might play a role in pathogenesis of PCOS. Genomewide association studies reported that FTO gene variants have an association with PCOS, mostly in Asians (Li et al., 2013) . The mechanism underlying the association of the FTO gene polymorphism with PCOS risk remains unclear. However, some studies have reported that FTO gene influence PCOS mainly via the association with obesity or obesity-related parameters such as BMI (Tan et Ramos et al., (2015) showed no association between SNPs in FTO and PCOS phenotype. The observed discrepancies may be due to variation in study design, sample size, demographic, ethnicity and genetic characteristics of differing study populations.
In this study, A allele (mutant allele) was more prevalent in PCOS women and T allele (normal allele) was more prevalent in control group. Furthermore, present study showed significant correlation between FTO gene polymorphism and BMI in PCOS group. This finding is consistent with former studies by Barber et al., (2008) and Farhan et al., (2015) .
In conclusion, this study is the first to determine any association between FTO gene variant rs9939609 and PCOS in Sri Lankan women. Our results demonstrate that the rs9939609 variant of FTO gene is significantly associated with PCOS among Sri Lankan women, probably by its effect on BMI.
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